News
Chugai, a Japanese company majority owned by Roche, has identified Gero’s platform as complementary to its own capabilities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback